- Home
- PLNT vs CORT Comparison
PLNT vs CORT Comparison
Compare PLNT & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLNT
- CORT
- Stock Information
- Founded
- PLNT 1992
- CORT 1998
- Country
- PLNT United States
- CORT United States
- Employees
- PLNT N/A
- CORT N/A
- Industry
- PLNT Hotels/Resorts
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- PLNT Consumer Discretionary
- CORT Health Care
- Exchange
- PLNT Nasdaq
- CORT Nasdaq
- Market Cap
- PLNT 8.1B
- CORT 7.5B
- IPO Year
- PLNT 2015
- CORT N/A
- Fundamental
- Price
- PLNT $109.51
- CORT $71.41
- Analyst Decision
- PLNT Strong Buy
- CORT Strong Buy
- Analyst Count
- PLNT 15
- CORT 4
- Target Price
- PLNT $106.60
- CORT $142.00
- AVG Volume (30 Days)
- PLNT 1.4M
- CORT 1.5M
- Earning Date
- PLNT 08-05-2025
- CORT 07-28-2025
- Dividend Yield
- PLNT N/A
- CORT N/A
- EPS Growth
- PLNT 21.55
- CORT 8.36
- EPS
- PLNT 2.11
- CORT 1.14
- Revenue
- PLNT $1,129,218,000.00
- CORT $685,446,000.00
- Revenue This Year
- PLNT $20.70
- CORT $35.83
- Revenue Next Year
- PLNT $10.29
- CORT $35.24
- P/E Ratio
- PLNT $51.96
- CORT $62.48
- Revenue Growth
- PLNT 10.26
- CORT 30.93
- 52 Week Low
- PLNT $68.75
- CORT $31.46
- 52 Week High
- PLNT $113.15
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- PLNT 57.84
- CORT 49.05
- Support Level
- PLNT $104.39
- CORT $70.09
- Resistance Level
- PLNT $108.36
- CORT $73.44
- Average True Range (ATR)
- PLNT 3.04
- CORT 2.64
- MACD
- PLNT 0.11
- CORT 0.04
- Stochastic Oscillator
- PLNT 61.96
- CORT 46.11
About PLNT Planet Fitness Inc.
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.